Appeal No. 2004-2317 Page 24 Application No. 09/771,938 August 10, 1999, which is prior to the filing date of the instant application. For clarity, we reproduce claims 8, 29 and 39 of the ‘145 patent below: 8. A corn plant having all the physiological and morphological characteristics of corn plant 87DIA4, a sample of the seed of said corn plant having been deposited under ATCC Accession No. 203192. 29. The corn plant of claim 8, further comprising a single gene conversion. 39. The single gene conversion of the corn plant of claim 29, where the gene confers enhanced yield stability. As we understand it, claim 39 of the ‘145 patent, is drawn to a corn plant which comprises a single gene conversion, wherein the gene confers enhanced yield stability. Thus, contrary to the examiner’s assertion it appears, for example, that a single gene that confers enhanced yield stability was known in the art prior to the filing date of the instant application. We remind the examiner “a patent need not teach, and preferably omits, what is well known in the art.” Hybritech Incorporated v. Monoclonal Antibodies, Inc. 802 F.2d 1367, 1385, 231 USPQ 81, 94 (Fed. Cir. 1986). We remind the examiner that the inquiry into whether the description requirement is met must be determined on a case-by-case basis and is a question of fact. Wertheim, 541 F.2d at 262, 191 USPQ at 96. A description as filed is presumed to be adequate; unless or until sufficient evidence or reasoning to the contrary has been presented by the examiner to rebut the presumption. See e.g., Marzocchi. The examiner, therefore, must have a reasonable basis to challenge the adequacy of the written description. Accordingly, it is the examiner who has the initial burden of establishing by a preponderance of evidence that a person skilled in the art would not recognize in an applicant’s disclosure aPage: Previous 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 NextLast modified: November 3, 2007